This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis. Using patient-completed questionnaires, combined with outpatient visit records and telephone follow-up, this study will explore the following aspects: Assess the incidence and severity of cancer-related fatigue in patients with malignant tumors. Analyze the influencing factors of cancer-related fatigue, including tumor type, treatment regimen, disease stage, efficacy of anti-tumor therapy, adverse events associated with anti-tumor therapy, and concomitant medications. Evaluate the impact of cancer-related fatigue on anti-tumor treatment and prognosis. Assess the multidimensional state and severity of cancer-related fatigue in patients with malignant tumors using the Brief Fatigue Inventory - Cancer (BFI-C) and the Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF). By collecting patients' medical information, including imaging and laboratory results, as well as outpatient and telephone follow-up records, this study will explore the following aspects: Evaluate the impact of different degrees of cancer-related fatigue on the prognosis of patients with malignant tumors. Explore the impact of the efficacy of anti-tumor therapy on the multidimensional state and severity of cancer-related fatigue in patients.
Study Type
OBSERVATIONAL
Enrollment
1,000,000
No Interventions
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
RECRUITINGThe incidence of cancer-related fatigue (CRF) in tumor patients.
The incidence of cancer-related fatigue (CRF) in tumor patients.
Time frame: Baseline
The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings.
The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings.
Time frame: Baseline
The correlation between treatment regimen and the incidence of cancer-related fatigue (CRF).
Time frame: Baseline
The incidence of anti-tumor treatment delays, dose reductions, or regimen modifications due to cancer-related fatigue (CRF).
Time frame: Baseline
Progression-free survival (PFS) and overall survival (OS) in patients with different grades of cancer-related fatigue (CRF) undergoing anti-tumor therapy.
Time frame: Baseline
To assess the state and severity of cancer-related fatigue (CRF) in patients with malignant tumors using the Brief Fatigue Inventory - Cancer (BFI-C) and the Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-SF).
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.